Company

Halozyme Therapeutics

Halozyme Therapeutics is tracked across RERIGHT’s news graph. Explore its connections and the latest headlines below.

Latest on Halozyme Therapeutics

  • 13F: Harvey Capital Management holds Halozyme Therapeutics ($11M)
  • 13F: Steelhead Partners Llc holds Halozyme Therapeutics ($39M)
  • 13F: Sidoxia Capital Management Llc holds Halozyme Therapeutics ($3M)

Connections

3 entities linked to Halozyme Therapeutics across the news graph.